We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermo Electron Acquires Instrument Validation Firm

By HospiMedica staff writers
Posted on 14 Nov 2003
In a transaction that will enable the company to offer instrument validation and other services to its customers, Thermo Electron Corp. (Waltham, MA, USA) has acquired Laboratory Management Systems Inc. (LMSi, New Castle, DE, USA). Terms were not disclosed.

LMSi specializes in performing instrument and computer systems validation, metrology, and certification. The company has developed a broad portfolio of analytical instrument validation protocols and operating procedures that enable laboratories to comply with US Food and Drug Administration requirements. LMSi had revenues of US$11 million in 2003.

"This acquisition is an important step in our strategy to offer customers comprehensive laboratory solutions that include full product support, for almost any instrument, anywhere,” said Marijn E. Dekkers, president and CEO of Thermo Electron. "Adding LMSi's regulatory and compliance expertise to our global laboratory service network will allow us to be a regulatory validation and consulting partner to customers who face increasing productivity, quality, and regulatory challenges.”




Related Links:
Thermo Electron
LMSi

Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
14 Nov 2003  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
14 Nov 2003  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
14 Nov 2003  |   Industry



PURITAN MEDICAL